Cargando…

The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study

OBJECTIVES: The objective of this study was to investigate the role of genetic status of DPC4 in recurrence patterns of resected pancreatic ductal adenocarcinoma (PDAC). METHODS: Between April 2004 and December 2011, data on patients undergoing surgical resection for PDAC were reviewed. Genetic stat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sang Hyun, Kim, Hwa Jung, Hwang, Dae Wook, Lee, Jae Hoon, Song, Ki Byung, Jun, Eunsung, Shim, In Kyong, Hong, Seung-Mo, Kim, Hyoung Jung, Park, Kwang-Min, Lee, Young-Joo, Kim, Song Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392299/ https://www.ncbi.nlm.nih.gov/pubmed/28160547 http://dx.doi.org/10.18632/oncotarget.14901

Ejemplares similares

Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998)

DPC4 Expression in the Small Intestinal Adenocarcinomas
por: Lee, Sun Jae, et al.
Publicado: (2012)

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
por: Sung, Min Kyu, et al.
Publicado: (2021)

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?
por: Ungefroren, Hendrik, et al.
Publicado: (2023)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer
por: Xu, Jin-Zhi, et al.
Publicado: (2019)

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
por: Shin, Jaehoon, et al.
Publicado: (2020)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Clinical Outcome of RAMPS for Left-Sided Pancreatic Ductal Adenocarcinoma: A Comparison of Anterior RAMPS versus Posterior RAMPS for Patients without Periadrenal Infiltration
por: Kwon, Jaewoo, et al.
Publicado: (2021)

Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε
por: Liffers, Sven-T, et al.
Publicado: (2011)

Analysis of the DPC4 Gene in Gastric Carcinoma
por: Nishizuka, Satoshi, et al.
Publicado: (1997)

Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery
por: Lee, Seung Jae, et al.
Publicado: (2022)

Expression and significance of transforming growth factor-β receptor type II and DPC4/Smad4 in non-small cell lung cancer
por: CHEN, HONG, et al.
Publicado: (2015)

Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Predictive Factors Associated with Complications after Laparoscopic Distal Pancreatectomy
por: Song, Ki Byung, et al.
Publicado: (2020)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011)

Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft
por: Jun, Eunsung, et al.
Publicado: (2017)

SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
por: Chen, Yu-Wen, et al.
Publicado: (2014)

Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma
por: Kwak, Bong Jun, et al.
Publicado: (2014)

Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

The Outcomes and Quality of Pancreatic Islet Cells Isolated from Surgical Specimens for Research on Diabetes Mellitus
por: Oh, Ju Yun, et al.
Publicado: (2022)

Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection
por: Kim, Young Il, et al.
Publicado: (2015)

Predictors of early recurrence following a curative resection in patients with a carcinoma of the ampulla of Vater
por: Ma, Chung Hyeun, et al.
Publicado: (2020)

Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma
por: Park, Min Young, et al.
Publicado: (2019)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
por: Dardare, Julie, et al.
Publicado: (2020)

Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas
por: Lee, Yangkyu, et al.
Publicado: (2017)

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma
por: Goh, Tae Sik, et al.
Publicado: (2019)

Integrating DPC++/oneAPI in the ATLAS software
por: Krasznahorkay, Attila
Publicado: (2023)

Evaluation of postoperative outcomes of minimally invasive distal pancreatectomy for left-sided pancreatic tumors based on the modified frailty index: a retrospective cohort study
por: Park, Yejong, et al.
Publicado: (2023)

Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Expression pattern of p-Smad2/Smad4 as a predictor of survival in invasive breast ductal carcinoma
por: Liu, Nannan, et al.
Publicado: (2020)

Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
por: Hsieh, Yao-Yu, et al.
Publicado: (2019)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
por: Lee, Jong Woo, et al.
Publicado: (2021)

The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target
por: Yoo, Wonbeak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_87coht4edmamhlgrrila1a1jfk